![]() Objective: To analyze the results of studies reflecting the mechanisms of development, risk factors, prevalence, diagnostic criteria and principles of treatment of NMS. Nevertheless, in 16% of patients, symptoms are recorded after 24 hours. This iatrogenic ышву уааусе develops within 4 weeks of starting therapy. Its prevalence ranges from 0.02% to 3.23%. Introduction: Malignant neuroleptic syndrome is a complication that occurs while taking high doses of drugs, more often antipsychotics. ![]() Voyno-Yasenetsky Krasnoyarsk State Medical University”, Krasnoyarsk, Russia.ģ Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation, Moscow Russian Bekhterev National Medical Research Center of Psychiatry and Neurology”" of the Ministry of Health of Russia, Saint-Petersburg, RussiaĢ Federal state budgetary institution of higher education “V.F.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |